Breast Cancer Research and Treatment

, Volume 117, Issue 1, pp 223–224 | Cite as

Sustained lower rates of breast cancer in the United States

  • Kathleen A. Cronin
  • Peter M. Ravdin
  • Brenda K. Edwards
Letter to the Editor


  1. 1.
    Ravdin PM, Cronin KA, Howlader N, Berg CD, Chlebowski RT, Feuer EJ, Edwards BK, Berry DA (2007) The decrease in breast-cancer incidence in 2003 in the United States. N Engl J Med 356(16):1670–1674. doi: 10.1056/NEJMsr070105 PubMedCrossRefGoogle Scholar
  2. 2.
    Surveillance, Epidemiology, and End Results (SEER) Program ( SEER*Stat Database: Incidence—SEER 9 Regs Limited-Use, Nov 2007 Sub (1973–2005) released April 2008, based on the November 2007 submission
  3. 3.
    Glass AG, Lacey JV Jr, Carreon JD, Hoover RN (2007) Breast cancer incidence, 1980–2006: combined roles of menopausal hormone therapy, screening mammography, and estrogen receptor status. J Natl Cancer Inst 99:1152–1161. doi: 10.1093/jnci/djm059 PubMedCrossRefGoogle Scholar
  4. 4.
    Canfell K, Banks E, Moa AM, Beral V (2008) Decrease in breast cancer incidence following a rapid fall in use of hormone replacement therapy in Australia. Med J Aust 188(11):641–644PubMedGoogle Scholar
  5. 5.
    Heiss G, Wallace R, Anderson GL, Aragaki A, Beresford SA, Brzyski R et al (2008) Health risks and benefits 3 years after stopping randomized treatment with estrogen and progestin. JAMA 299:1036–1045. doi: 10.1001/jama.299.9.1036 PubMedCrossRefGoogle Scholar

Copyright information

© Springer Science+Business Media, LLC. 2008

Authors and Affiliations

  • Kathleen A. Cronin
    • 1
  • Peter M. Ravdin
    • 2
  • Brenda K. Edwards
    • 1
  1. 1.Division of Cancer Control and Population SciencesNational Cancer InstituteBethesdaUSA
  2. 2.Department of BiostatisticsM.D. Anderson Cancer CenterHoustonUSA

Personalised recommendations